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The presented dataset describes the quantiﬁcation of carbon
nanoparticle C60 fullerene accumulated in mitochondria of human
leukemic cells treated with nanostructure. Firstly, the high per-
formance liquid chromatography–electro spray ionization–mass
spectrometry (HPLC-ESI-MS) method was developed for quanti-
tative analysis of pristine C60 fullerene. Then, human leukemic
cells were incubated with C60 fullerene, homogenized and sub-
jected to the differential centrifugation to retrieve mitochondrial
fraction. The C60 fullerene content was quantiﬁed by HPLC-ESI-MS
in extracts of cellular fractions.
This data article refers to the research article “C60 Fullerene
Accumulation in Human Leukemic Cells and Perspectives of LED-
mediated Photodynamic Therapy” by Grebinyk et al. [1].
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Dubject area Biology, Chemistry
ore speciﬁc subject area Nanoparticle uptake
Liquid chromatography–mass spectrometry
ype of data Table, ﬁgures with graphs
ow data was acquired UV-Spectrophotometer UV-1800 (Shimadzu, Kyoto, Japan)
Nexera HPLC system coupled to the LCMS-8040 Tandem Quadrupole
Mass Spectrometer, equipped with an Electro Spray Ionization source
(Shimadzu, Kyoto, Japan)ata format Analyzed data
xperimental factors Human leukemic cells CCRF-CEM incubated in the presence of 20 mM C60
fullerene for 24 h
xperimental features HPLC-ESI-MS analysis of C60 fullerene content in human leukemic cell
homogenate and cellular fractions
ata source location Hochschulring 1, 15745 Wildau, Germany
ata accessibility Data are available with this articleDValue of the data
 The data article presents a novel HPLC-ESI-MS method for quantitative analysis of pristine C60
fullerene intracellular content.
 The experimental design combines different steps and various methodologies, starting from cell
culture up to mass spectrometry analysis.
 The developed set-up could be used to quantify the content and distribution of pristine C60
fullerene and other carbon nanostructures in cell and its compartments.1. Experimental design and data
Quantiﬁcation of a nanostructure distribution within the cell enlightens its possible impact on
whole cell metabolism. Herein, we present a novel high performance liquid chromatography–electro
spray ionization–mass spectrometry (HPLC-ESI-MS) quantiﬁcation method of intracellular content of
carbon nanostructure – C60 fullerene. This data article refers to the recent work by Grebinyk et al. [1].
Liquid chromatography separation and mass spectrometric detection were achieved by employing
the Nexera HPLC system coupled to the LCMS-8040 Tandem Quadrupole Mass Spectrometer,
equipped with an ESI source (Shimadzu, Kyoto, Japan). Chromatographic separation was performed
using the column Eclipse XDV-C8 150mm  4.6. mm, 5 μm(Agilent, Santa Clara, USA) with an iso-
cratic mobile phase of toluene and methanol (45:55, v-v). Chromatographic conditions and optimized
MS parameters are presented in Table 1. For data processing the software LabSolutions LCMS (Shi-
madzu, Kyoto, Japan) was used.
MS chromatograms of C60 fullerene (retention time ¼ 3.21min) were acquired using single ion
monitoring (SIM) mode in positive regime with target molecular ion ¼ 720 [M]þ m/z (Fig. 1A).
Acquisition time was 0.2 s. Quantiﬁcation was achieved using regression curves in the range 0.0005–
5 mg/ml (Fig. 1B). The regression equation was “y ¼ (3.86582e þ 006)x þ 92537”. The limit of detec-
tion (LOD) was deﬁned according to: LOD ¼ 3.3  s/Slope, where s is the standard deviation of the
regression line. The Limit of quantiﬁcation (LOQ) was estimated by the serial dilution of the standard
solution (n ¼ 3 per dilution) and deﬁned as the concentration at which precision was r 20%. The
good linearity ranges were achieved by the analysis of linear correlation coefﬁcient for C60
r ¼ 0.99986. All the analyses were performed in triplicate, and the peak areas were measured.
Fig. 1. Data of the developed HPLC-ESI-MS method for C60 fullerene detection and quantiﬁcation: A – representative SIM-
chromatogram of C60 fullerene from cell extract, B – calibration curve with methods performance characteristics used for
nanoparticle content quantiﬁcation.
Table 1
HPLC-ESI-MS conditions for analysis of C60 fullerene.
Chromatographic conditions
Column Agilent Eclipse XDB-C8
Column temperature 40 °C
Mobile phase methanol:toluene (45:55, v-v)
Flow rate 0.7mlmin
Run time 5min
Injection volume 3 ml
MS conditions
Ionization source ESI
desolvation line temperature 250 °C
heat block temperature 400 °C
Target molecular ion 720 [M]þ m/z
Time window 0–5min
Dwell time 0.2 s
Interface voltage 4.5 kV
Nebulizing gas ﬂow 3 l/min
Drying gas ﬂow 15 l/min
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up to mass spectrometry as well as obtained relative data (Fig. 2). The aim was set to quantify C60
fullerene content in the mitochondria of leukemic cells with above presented HPLC-ESI-MS
method. For that, human leukemic cells CCRF-CEM were incubated in the presence of C60 full-
erene for 24 h followed by homogenization and differential centrifugation. Succinate-reductase
activity was used as a mitochondrial marker to test fraction enrichment and purity (Fig. 2B).
Finally, C60 fullerene concentration was estimated in cellular fractions (Fig. 2C).
Fig. 2. C60 fullerene mitochondrial content quantiﬁcation: A – Isolation of mitochondria, B – Succinate-reductase activity of
obtained cellular fractions, C – C60 fullerene distribution among cellular fractions.
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2.1. Chemicals
RPMI 1640 liquid medium, phosphate buffered saline (PBS), Fetal Bovine Serum (FBS), Penicillin/
Streptomycin and L-glutamin were obtained from Biochrom (Berlin, Germany). C60 fullerene, sucrose,
trichloroacetic acid, Coomassie Brilliant Blue G-250, ethanol and bovine serum albumin (BSA) were
obtained from Sigma-Aldrich Co. (St-Louis, USA). Toluene, methanol, 2-isopropanol, acetonitrile, tris
(hydroxymethyl)aminomethane (Tris), ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic
acid (EGTA) and phosphoric acid from Carl Roth GmbHþCo. KG (Karlsruhe, Germany) were used. 3-
(N-morpholino)propanesulphonic acid (MOPS) was purchased from ICN Biomedicals Inc. (Ohio, USA).
2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium (INT) and ethyl acetate were obtained
from Acros Organics (Geel, Belgium).
2.2. C60 fullerene aqueous colloid solution preparation
The pristine C60 fullerene aqueous colloid solution was prepared as described in [2] by C60 full-
erene transfer from toluene to water using continuous ultrasound sonication. Obtained C60 colloid
solution was characterized by high C60 fullerene concentration (2  104М, purity 99%), stability and
homogeneity.
2.3. Cell culture
The human cancer cell line of leucosis origin – CCRF-CEM (ACC 240) – was purchased from the
Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures. Cells were main-
tained in RPMI 1640 medium supplemented with 10% Fetal Bovine Serum, 1% Penicillin/Streptomycin
and 2mM Glutamine, using 25 cm2 ﬂasks at a 37 °C with 5% CO2 in a humidiﬁed incubator Binder
(Tuttlingen, Germany). The number of viable cells was counted using 0.1% trypan blue staining and a
Roche Cedex XS Analyzer (Basel, Switzerland).
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CCRF-CEM cells (2  105/ml) were seeded in 6-well plate Sarstedt (Nümbrecht, Germany). After
24 h cells were incubated for 0–48 h in the presence of 20 mM C60, washed with PBS three times and
transferred to the dH20. The freeze-thawing cycle was repeated three times. The probes were dried at
80 °C under reduced pressure. Toluene/2-propanol (6:1, v/v) was added in the ﬁnal volume 0.5ml, the
mixture was sonicated for 1 h and centrifuged (70min, 20 238 g). The toluene layer was analyzed
with HPLC-ESI-MS.2.5. Isolation of mitochondria
CCRF-CEM cells were incubated for 24 h in the presence of 20 mM C60 from aqueous colloid
solution and the mitochondria fraction was isolated accordingly to [3]. Cell suspension (5  106/4ml)
was centrifuged at 600 g at 4 °C for 10min, cells were resuspended in 3ml of ice cold isolation buffer
(0.01M Tris-MOPS, 1mM EGTA/Tris, 0.2M sucrose, pH 7.4) and homogenized in the teﬂon-glass
potter on ice. The homogenate was centrifuged at 600 g at 4 °C for 10min. The collected supernatant
(S1) was centrifuged at 7000 g at 4 °C for 10min. The pellet (P2) was resuspended in 200 ml ice-cold IB
and centrifuged at 7000 g at 4 °C for 10min. The mitochondrial fraction obtained in pellet (P3) was
used for extraction of C60 fullerene as well as for measurements of protein concentration [4] and
succinate-reductase (SR, EC 1.3.5.1) activity as mitochondrial marker [5].
2.5.1. Protein concentration assay
The protein concentration colometric assay is based on the proportional binding of the dye Coo-
massie to proteins, changing its color from brown to blue. Aliquots of both homogenate and all
fractions after differential centrifugation were used to determine the protein concentration. After
incubation with 0.01% Coomassie working solution in 4.7% ethanol and 8.5% phosphoric acid for 5
min. Protein concentration was estimated at 595 nm, using BSA as a protein standard.
2.5.2. Succinate-reductase activity assay
Succinate-reductase activity colometric assay is based on the reduction of a tetrazolium salt INT to
cyan farmazan. 50 ml aliquotes of homogenate as well as of fractions after differential centrifugation
were shaken for 15min at 37 °C in 0.5ml of the working solution (0.1% INT, 50mM sodium succinate,
25mM sucrose in 50mM potassiumphosphat buffer, pH 7.4). To stop the reaction the proteins were
precipitated with 0.5ml 25% trichloroacetic acid. The farmazan was extracted with 2ml ethyl acetate.
The absorption of organic colored layer was analyzed at λ ¼ 492 nm with UV-Spectrophotometer UV-
1800 (Shimadzu, Kyoto, Japan). The succinate-reductase activity was calculated using extinction
coefﬁcient (ΔE) by the following formula:
SR Activity Units ½μM=h=mg Protein ¼ 4 ΔE=20:1=Protein ConcentrationAcknowledgments
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